Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study of the VISION5 Product in Patients With Glaucoma or Ocular Hypertension

NCT01943721 is registered in ClinicalTrials.gov with ForSight Vision5, Inc. as lead sponsor.

NCT NCT01943721
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01943721 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study of the VISION5 Product in Patients With Glaucoma or Ocular Hypertension
Lead sponsor
ForSight Vision5, Inc.
Phase
Phase 1
Overall status
Completed
Start date
October 31, 2013
Completion date
June 30, 2014
Enrollment
14 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ocular hypertension, primary open angle glaucoma